Sky Century Investment (SKYI) Free Cash Flow (2012 - 2026)
Sky Century Investment's (SKYI) quarterly Free Cash Flow came in at -$59238.0 in Q2 2026, down 246.41% year-on-year from $40460.0 in Q2 2025, and down 2813.61% on a QoQ basis from $2183.0 in Q1 2026.
Sky Century Investment (SKYI) Free Cash Flow (2012 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 6 years of Free Cash Flow data on file, last reported at -$59238.0 in Q2 2026.
- On a quarterly basis, Free Cash Flow fell 246.41% year-over-year to -$59238.0 in Q2 2026; TTM through May 2026 was -$37040.0, a 202.19% decrease from a year earlier, with the FY2025 full-year figure at $30941.0, up 6275.85% from the prior year.
- Free Cash Flow for Q2 2026 stood at -$59238.0, down from $2183.0 in the prior quarter.
- Over the last five years, Free Cash Flow for SKYI reached as high as $40460.0 in Q2 2025 and fell as low as -$59238.0 in Q2 2026.
- Historically, Free Cash Flow has averaged -$1728.5 across 3 years, with a median of -$6051.5 in 2024.
- Across the five-year window, Free Cash Flow jumped 786.58% in 2025 and sank 246.41% in 2026, its largest moves.
- Year by year, Free Cash Flow stood at -$10827.0 in 2024, then jumped by 42.64% to -$6210.0 in 2025, then slumped by 853.91% to -$59238.0 in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$59238.0 in Q2 2026, $2183.0 in Q1 2026, and -$6210.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Sky Century Investment | 1.06 Mn | 1.06 Mn | 26,045.00 | -59,238.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -59,238.00 |
| May 31, 2026 | -59,238.00 |
| Feb 28, 2026 | 2,183.00 |
| Feb 28, 2026 | 2,183.00 |
| Nov 30, 2025 | -6,210.00 |
| Nov 30, 2025 | -6,210.00 |
| Aug 31, 2025 | 26,225.00 |
| Aug 31, 2025 | 26,225.00 |
| May 31, 2025 | 40,460.00 |
| May 31, 2025 | 40,460.00 |
| Feb 28, 2025 | -9,377.00 |
| Feb 28, 2025 | -9,377.00 |
| Nov 30, 2024 | -10,827.00 |
| Nov 30, 2024 | -10,827.00 |
| Aug 31, 2024 | 15,990.00 |
| Aug 31, 2024 | 15,990.00 |
| May 31, 2024 | -5,893.00 |
| May 31, 2024 | -5,893.00 |
| Feb 29, 2024 | -10,598.00 |
| Feb 29, 2024 | -10,598.00 |